Dysferlin is a surface membrane–associated protein that is absent in Miyoshi myopathy
The DOI matches its Crossref record.
Abstract
Background and objectives The CGEP (French acronym for the College of General Practitioners of East Paris) is an independent association with no funding from industry which has been certified by HAS (French National Authority for Health) and CNFMC (National Councils for Continuous Medical Education). Its members are private and salaried general practitioners. The objective of CGEP is to improve health by improving care through the use of good practice indicators (GPI). The focus is on practice improvement (the aim) rather than on practice assessment per se (the tool). Programme This was a 3-year programme initiated in 2007, run by the association9s committee, and with 29 participating GPs. The programme involves an analysis of practice and sharing of experience by GPs on chosen GPIs for common diseases (in particular iatrogenic disease, sleep disturbances, orders for tests, diabetes, and hypertension). The GPI criteria were reliability of the recommendations (ie, no conflict of interest with the health care industry), their relevance to professional practice, and feasibility within the scope of general practice. These criteria are potential guarantors of health improvements through guideline implementation. Practice analysis and sharing of experience occurred twice at a 6 to 12 months interval. Participants received guides on each indicator for practice analysis. They were able to make qualitative and quantitative comparisons of their own practice over time and also compare their practice with that of their peers at different times. The indicators were also used to measure trends in practice for the whole group. Results No participant dropped out suggesting that the initiative was relevant and feasible. There was a positive trend towards compliance with guideline recommendations by almost all participants and especially by the group as a whole (eg, for orders for tests, diabetes, child obesity). For example, group compliance showed increases: from 37% to 86% of patient files for the GPI ‘no a non steroidal anti-inflammatory drug during pregnancy’ (iatrogenic disease during pregnancy); from 33% to 79% for the GPI ‘advice on the correct use of condoms’ (sexually transmitted infections); from 37% to 56% for the GPI ‘prescription of alternatives to benzodiazepines’ (sleep disturbances). Although compliance is a surrogate endpoint for determining clinical impact, it is nevertheless essential. Discussion and conclusion Relevant and reliable GPIs are essential. Without them, there is no practice improvement plan and consequently no managed clinical improvement. However, GPIs are few and far between despite work done by HAS and the first-rate journal Prescrire. CGEP plans to turn the present initiative into a permanent project but its scope of action is seriously hampered by administrative ‘beating about the bush’ and by mandatory participation of GPs in various schemes (CME/PPA/CDP). The participation of specialists and allied health professionals, besides GPs, would probably be an asset. We plan to invite interested specialists, pharmacists, nurses and other allied health professionals to join us in the management of common diseases in order to put the patient back at the centre of the action. Le Collège des Généralistes de l9Est Parisien, association 1901 strictement indépendante de tout financement industriel, est un organisme agréé (HAS et CNFMC). Le CGEP regroupe des médecins généralistes libéraux et salariés. L9objectif du CGEP est l9amélioration de la santé par l9amélioration des soins reposant sur des indicateurs de bonne pratique (IBP). Le CGEP a préféré le terme d9Amélioration des pratiques professionnelles (APP) au terme d9EPP qui constitue un outil et non une finalité. Programme Ce programme a été mis en place en 2007. Il se déroule sur 3 ans. 29 professionnels, généralistes libéraux et salariés, y sont inscrits. Il repose sur une analyse de la pratique couplée à un échange de pratiques entre professionnels concernant des indicateurs choisis dans les pathologies fréquentes (notamment Pathologies iatrogènes, Troubles du sommeil, Prescription d9examens complémentaires, Diabète, HTA). Le programme est mis en œuvre par les membres du bureau de l9association. Les critères des indicateurs de bonne pratique sélectionnés par le groupe EPP-CGEP sont: fiabilité (recommandations indemnes de conflits d9intérêts avec l9industrie de la santé), pertinence (par rapport à la pratique des professionnels), faisabilité (dans le cadre de l9exercice professionnel), garantes de leur mise en œuvre en vue de l9amélioration de santé de la population en charge. L9analyse et l9échange des pratiques se fait 2 fois, espacées de 6 à 12 mois. Les participants reçoivent des ‘aide-mémoire’ concernant chacun des indicateurs sur lesquels a porté leur analyse de pratique. Les participants peuvent ainsi, qualitativement et quantitativement, comparer l9évolution de leur propre pratique et comparer leur pratique à celle de leurs pairs à plus
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strains
MOY, S., NADLER, J., YOUNG, N., PEREZ, A., HOLLOWAY, L., BARBARO, R., BARBARO, J., WILSON, L., THREADGILL, D., & LAUDER, J. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.030 · Cited by 776
Molecular basis of muscular dystrophies
Cohn, R. D., & Campbell, K. P. (2000) · Muscle & Nerve · doi:10.1002/1097-4598(200010)23:10<1456::aid-mus2>3.0.co;2-t · Cited by 538
Dysferlin Interacts with Annexins A1 and A2 and Mediates Sarcolemmal Wound-healing
Lennon, N. J., Kho, A., Bacskai, B. J., Perlmutter, S. L., Hyman, B. T., & Brown, R. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307247200 · Cited by 408
Self-citationDysferlin and the plasma membrane repair in muscular dystrophy
Bansal, D., & Campbell, K. P. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.03.001 · Cited by 338
Illa, I., Serrano-Munuera, C., Gallardo, E., Lasa, A., Rojas-Garc�a, R., Palmer, J., Gallano, P., Baiget, M., Matsuda, C., & Brown, R. H. (2001) · Annals of Neurology · doi:10.1002/1531-8249(200101)49:1<130::aid-ana22>3.0.co;2-0 · Cited by 278
Self-citation
Metadata
- Authors
- Matsuda, C., Aoki, M., Hayashi, Y. K., Ho, M. F., Arahata, K., & Brown, R. H.
- Venue
- Neurology
- Published
- 1999-09
- Volume
- 53
- Issue
- 5
- Pages
- 1119-1119
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2004484191
- Cited by
- 141
- References
- 0
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dysferlin is a surface membrane–associated protein that is absent in Miyoshi myopathy. https://app.cochat.ai/papers/10.1212/wnl.53.5.1119
- The paper
- Matsuda, C., Aoki, M., Hayashi, Y. K., Ho, M. F., Arahata, K., & Brown, R. H. (1999). Dysferlin is a surface membrane–associated protein that is absent in Miyoshi myopathy. Neurology. https://doi.org/10.1212/wnl.53.5.1119
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.